Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07576023
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic DermatitisPierre Fabre Dermo CosmetiqueCompletedNot Applicable
NCT07576023Completed
Not Applicable
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in...Pierre Fabre Dermo Cosmet...
NCT07575945
A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Healthy Adults.PfizerNot Yet RecruitingPhase 1
NCT07575945Not Yet Recruiting
Phase 1
A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processe...Pfizer
NCT07575451
Empowering Families in Pediatric Cardiovascular Surgery: A RAM-Based ApproachCukurova UniversityNot Yet RecruitingNot Applicable
NCT07575451Not Yet Recruiting
Not Applicable
Empowering Families in Pediatric Cardiovascular Surgery: A RAM-Based ApproachCukurova University
NCT07575308
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMBAlnylam PharmaceuticalsNot Yet RecruitingPhase 2
NCT07575308Not Yet Recruiting
Phase 2
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Pa...Alnylam Pharmaceuticals
NCT07576764
Pediatric Prolonged-Release Melatonin for Sleep Disturbances in Children and Adolescents With Anorexia Nervosa (MELSom-ANOREXIA)Assistance Publique Hopitaux De MarseilleNot Yet RecruitingPhase 3
NCT07576764Not Yet Recruiting
Phase 3
Pediatric Prolonged-Release Melatonin for Sleep Disturbances in Children and Ado...Assistance Publique Hopit...
NCT07575217
Mail-in HPV Screening Program in NJRutgers, The State University of New JerseyNot Yet RecruitingNot Applicable
NCT07575217Not Yet Recruiting
Not Applicable
Mail-in HPV Screening Program in NJRutgers, The State Univer...
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07575061
A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal TuberculosisBeijing Chest Hospital, Capital Medical UniversityRecruiting
NCT07575061Recruiting
—
A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal...Beijing Chest Hospital, C...
NCT07575581
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul UniversityCompleted
NCT07575581Completed
—
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul University
NCT07574450
Taiwan ED Airway Quality Surveillance Registry (TEAR)Chang Gung Memorial HospitalNot Yet Recruiting
NCT07574450Not Yet Recruiting
—
Taiwan ED Airway Quality Surveillance Registry (TEAR)Chang Gung Memorial Hospi...
NCT07576673
Self-Cure vs. Highly Filled Flowable Composite in Carious Cervical Lesions: 18-Month RCTCairo UniversityNot Yet RecruitingNot Applicable
NCT07576673Not Yet Recruiting
Not Applicable
Self-Cure vs. Highly Filled Flowable Composite in Carious Cervical Lesions: 18-M...Cairo University
NCT07575360
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Cholecystitis PatientsUniversity of BolognaCompleted
NCT07575360Completed
—
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Chole...University of Bologna
NCT07576647
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)McMaster UniversityNot Yet RecruitingNot Applicable
NCT07576647Not Yet Recruiting
Not Applicable
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision...McMaster University
NCT07576504
Sensorimotor Technique on Navicular Drop in School Going ChildrenRiphah International UniversityRecruitingNot Applicable
NCT07576504Recruiting
Not Applicable
Sensorimotor Technique on Navicular Drop in School Going ChildrenRiphah International Univ...
NCT07574489
Whole Versus Partial Gland Boost During Prostate SBRTUniversity of NebraskaNot Yet RecruitingPhase 2
NCT07574489Not Yet Recruiting
Phase 2
Whole Versus Partial Gland Boost During Prostate SBRTUniversity of Nebraska
NCT07575256
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion FracturesBeijing Tsinghua Chang Gung HospitalNot Yet RecruitingNot Applicable
NCT07575256Not Yet Recruiting
Not Applicable
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior...Beijing Tsinghua Chang Gu...
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07574957
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNAAssistance Publique - Hôpitaux de ParisNot Yet Recruiting
NCT07574957Not Yet Recruiting
—
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of...Assistance Publique - Hôp...
NCT07576127
Effects of Gongs Mobilization and Proprioceptive Neuromuscular Facilitation in Patients With Adhesive CapsulitisRiphah International UniversityRecruitingNot Applicable
NCT07576127Recruiting
Not Applicable
Effects of Gongs Mobilization and Proprioceptive Neuromuscular Facilitation in P...Riphah International Univ...
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
Result Breakdown
Not yet recruiting14 (70%)
Completed3 (15%)
Recruiting3 (15%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 23 (15%)
Phase 12 (10%)
Phase 31 (5%)